Please select the option that best describes you:
Topics:
Critical Care • Hospital Medicine • Primary Care • Urgent Care • General Primary Care • General Hospital Medicine
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g. rhinovirus, non-COVID coronavirus, human metapneumovirus, etc)?